Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Mbio|July 13, 2021
<i>In Vivo</i> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 ExpressionSilvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, et al.
Plos One|March 28, 2015
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibodySarah De Baets, Judith Verhelst, Silvie Van den Hoecke, et al.
Frontiers in Immunology|January 11, 2020
Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus InfectionDorien De Vlieger, Katja Hoffmann, Inge Van Molle, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2015
GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturationThomas Naessens, Bert Schepens, Muriel Smet, et al.
Molecular Therapy. Nucleic Acids|May 22, 2020
mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in MiceLien Van Hoecke, Rein Verbeke, Dorien De Vlieger, et al.
Plos One|March 26, 2013
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza ALorena Itatí Ibañez, Kenny Roose, Marina De Filette, et al.
Human Vaccines & Immunotherapeutics|June 13, 2020
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic proteinHeather L Torrey, Valarmathy Kaliaperumal, Yogesh Bramhecha, et al.
Biomaterials|March 26, 2018
Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonistLutz Nuhn, Lien Van Hoecke, Kim Deswarte, et al.
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
The Journal of Infectious Diseases|October 15, 2011
Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusionBert Schepens, Lorena Itatí Ibañez, Sarah De Baets, et al.
Pageof 6